Hodel Lucas, Inci Ilhan, Schanz Urs, Vrugt Bart, Weder Walter, Hillinger Sven
Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Department of Hematology, University Hospital Zurich, Zurich, Switzerland.
J Thorac Dis. 2018 Mar;10(3):E175-E178. doi: 10.21037/jtd.2018.03.01.
We present an exemplary case of an immunocompromised patient with pulmonary mucormycosis successfully treated by a combination of surgical removal of the mucor and urokinase to control the recurring hemothorax. The use of urokinase in hemothoraces is a way to reduce repetitive surgeries in weak patients.
我们展示了一个免疫功能低下的肺毛霉病患者的典型病例,该患者通过手术切除毛霉和使用尿激酶控制复发性血胸的联合治疗成功治愈。在血胸中使用尿激酶是减少体弱患者重复手术的一种方法。